Literature DB >> 30770218

Inactivation of Apoptosis Antagonizing Transcription Factor in tubular epithelial cells induces accumulation of DNA damage and nephronophthisis.

Manaswita Jain1, Rainer W J Kaiser1, Katrin Bohl1, Martin Hoehne2, Heike Göbel3, Malte P Bartram1, Sandra Habbig4, Roman-Ulrich Müller2, Agnes B Fogo5, Thomas Benzing2, Bernhard Schermer2, Katja Höpker1, Gisela G Slaats6.   

Abstract

Recent human genetic studies have suggested an intriguing link between ciliary signaling defects and altered DNA damage responses in nephronophthisis (NPH) and related ciliopathies. However, the molecular mechanism and the role of altered DNA damage response in kidney degeneration and fibrosis have remained elusive. We recently identified the kinase-regulated DNA damage response target Apoptosis Antagonizing Transcription Factor (AATF) as a master regulator of the p53 response. Here, we characterized the phenotype of mice with genetic deletion of Aatf in tubular epithelial cells. Mice were born without an overt phenotype, but gradually developed progressive kidney disease. Histology was notable for severe tubular atrophy and interstitial fibrosis as well as cysts at the corticomedullary junction, hallmarks of human nephronophthisis. Aatf deficiency caused ciliary defects as well as an accumulation of DNA double strand breaks. In addition to its role as a p53 effector, we found that AATF suppressed RNA:DNA hybrid (R loop) formation, a known cause of DNA double strand breaks, and enabled DNA double strand break repair in vitro. Genome-wide transcriptomic analysis of Aatf deficient tubular epithelial cells revealed several deregulated pathways that could contribute to the nephronophthisis phenotype, including alterations in the inflammatory response and anion transport. These results suggest that AATF is a regulator of primary cilia and a modulator of the DNA damage response, connecting two pathogenetic mechanisms in nephronophthisis and related ciliopathies.
Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AATF; DNA damage; DNA repair; R loop; ciliopathy; nephronophthisis; primary cilia

Mesh:

Substances:

Year:  2019        PMID: 30770218     DOI: 10.1016/j.kint.2018.10.034

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

1.  Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma.

Authors:  Tiziana Bruno; Francesca De Nicola; Giacomo Corleone; Valeria Catena; Frauke Goeman; Matteo Pallocca; Cristina Sorino; Gianluca Bossi; Bruno Amadio; Giovanni Cigliana; Maria Rosaria Ricciardi; Maria Teresa Petrucci; Enrico Pierluigi Spugnini; Alfonso Baldi; Mario Cioce; Giancarlo Cortese; Elisabetta Mattei; Roberta Merola; Umberto Gianelli; Luca Baldini; Francesco Pisani; Svitlana Gumenyuk; Andrea Mengarelli; Katja Höpker; Thomas Benzing; Bruno Vincenzi; Aristide Floridi; Claudio Passananti; Giovanni Blandino; Simona Iezzi; Maurizio Fanciulli
Journal:  Blood Adv       Date:  2020-11-24

Review 2.  Renal Ciliopathies: Sorting Out Therapeutic Approaches for Nephronophthisis.

Authors:  Marijn F Stokman; Sophie Saunier; Alexandre Benmerah
Journal:  Front Cell Dev Biol       Date:  2021-05-13

3.  Extensive Inter-Cyst DNA Methylation Variation in Autosomal Dominant Polycystic Kidney Disease Revealed by Genome Scale Sequencing.

Authors:  Sarah A Bowden; Peter A Stockwell; Euan J Rodger; Matthew F Parry; Michael R Eccles; Cherie Stayner; Aniruddha Chatterjee
Journal:  Front Genet       Date:  2020-04-15       Impact factor: 4.599

4.  Apoptosis-antagonizing transcription factor is involved in rat post-traumatic epilepsy pathogenesis.

Authors:  Wei Wang; Yu-Min Ma; Zheng-Lin Jiang; Zhi-Wei Gao; Wei-Guan Chen
Journal:  Exp Ther Med       Date:  2021-01-27       Impact factor: 2.447

Review 5.  Altered DNA methylation in kidney disease: useful markers and therapeutic targets.

Authors:  Kaori Hayashi
Journal:  Clin Exp Nephrol       Date:  2022-01-13       Impact factor: 2.801

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.